Last reviewed · How we verify
Ginaton
At a glance
| Generic name | Ginaton |
|---|---|
| Also known as | Ginkgo biloba extract,GBE |
| Sponsor | Peking University People's Hospital |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Efficacy and Safety of Ginkgo Biloba Extract EGb761® in Patients With Diabetic Retinopathy (PHASE2)
- The Study of Wuling Capsule in Treatment Chronic Tinnitus (NA)
- Efficacy of Diterpene Ginkgolides Meglumine Injection in Elderly Patients With Ischemic Stroke (NA)
- The Effect of PAP on ISSHL Comorbided With OSA (PHASE4)
- Efficacy and Safety of Qinggongshoutao Bolus in aMnestic Mild Cognitive Impairment (PHASE4)
- Sudden Hearing Loss Multi-center Clinical Trial (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ginaton CI brief — competitive landscape report
- Ginaton updates RSS · CI watch RSS
- Peking University People's Hospital portfolio CI